Keywords: acambis, sees, flat, 1st-qtr, sales, losses, double

Acambis sees flat 1st-qtr sales and losses double

Article | 15 May 2006

Print This

UK-based vaccine developer Acambis saw first-quarter 2006 sales flat at L6.0 million ($11.2 million), with R&D costs up 36% at L9.8 million. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in